Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT05354297

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
LifeScan (from the registry)
Registry
  • NCT NCT05354297
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05354297. Non-randomized; no masking; primary purpose treatment. Start 2022-07-26 (anticipated); primary completion 2023-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions
Acronym
ECLIPSE
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Cecelia Health plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
Intervention (Device)
Fitbit plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
Intervention (Device)
Noom plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app
Intervention (Device)
Welldoc plus OneTouch Verio Reflect® BGM and Welldoc app
Lead sponsor
LifeScan (class: industry)
Collaborator
Evidation Health (class: industry)

Record details

Record id
cardio:ct-nct05354297
Content hash
c465a81c7da191c77bf6a049be4f880d4457458905694044bc8fe14fb43a7c51